BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25368277)

  • 21. Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.
    Witzens-Harig M; Hensel M; Unterhalt M; Herfarth K
    BMC Cancer; 2011 Feb; 11():87. PubMed ID: 21352561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy.
    Campbell BA; Voss N; Woods R; Gascoyne RD; Morris J; Pickles T; Connors JM; Savage KJ
    Cancer; 2010 Aug; 116(16):3797-806. PubMed ID: 20564082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
    Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
    Tarella C; Zanni M; Magni M; Benedetti F; Patti C; Barbui T; Pileri A; Boccadoro M; Ciceri F; Gallamini A; Cortelazzo S; Majolino I; Mirto S; Corradini P; Passera R; Pizzolo G; Gianni AM; Rambaldi A
    J Clin Oncol; 2008 Jul; 26(19):3166-75. PubMed ID: 18490650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose radiotherapy in indolent lymphomas, enough is enough.
    Haas RL
    Hematol Oncol; 2009 Jun; 27(2):71-81. PubMed ID: 19266491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
    Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
    Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
    J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is radiotherapy curative for stage-I and -II low-grade follicular lymphomas? The results a long-term follow-up study of patients treated at Stanford University].
    Sack H
    Strahlenther Onkol; 1996 Dec; 172(12):691-3. PubMed ID: 8992640
    [No Abstract]   [Full Text] [Related]  

  • 30. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodal follicular lymphoma: the role of radiotherapy for stages I and II.
    Heinzelmann F; Engelhard M; Ottinger H; Bamberg M; Weinmann M
    Strahlenther Onkol; 2010 Apr; 186(4):191-6. PubMed ID: 20354662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
    Sehn LH; MacDonald D; Rubin S; Cantin G; Rubinger M; Lemieux B; Basi S; Imrie K; Gascoyne RD; Sussman J; Chen BE; Djurfeldt M; Shepherd L; Couban S; Crump M
    J Clin Oncol; 2011 Sep; 29(25):3396-401. PubMed ID: 21810681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
    Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment strategies in limited stage follicular NHL.
    Hoppe RT
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):179-86. PubMed ID: 21658617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma.
    Besa PC; McLaughlin PW; Cox JD; Fuller LM
    Cancer; 1995 May; 75(9):2361-7. PubMed ID: 7712449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?
    Kahn S; Flowers C; Xu Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):175-80. PubMed ID: 20732769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
    El-Galaly TC; Bilgrau AE; de Nully Brown P; Mylam KJ; Ahmad SA; Pedersen LM; Gang AO; Bentzen HH; Juul MB; Bergmann OJ; Pedersen RS; Nielsen BJ; Johnsen HE; Dybkaer K; Bøgsted M; Hutchings M
    Br J Haematol; 2015 May; 169(3):435-44. PubMed ID: 25709094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
    König L; Dreyling M; Dürig J; Engelhard M; Hohloch K; Viardot A; Witzens-Harig M; Kieser M; Klapper W; Pott C; Herfarth K
    Trials; 2019 Aug; 20(1):544. PubMed ID: 31470902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.